Takara Bio Inc.
4974.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | ¥10 | ¥9 | ¥16 | ¥10 |
| % Growth | 2.8% | -41.2% | 65.4% | – |
| Cost of Goods Sold | ¥4 | ¥4 | ¥6 | ¥6 |
| Gross Profit | ¥6 | ¥5 | ¥10 | ¥4 |
| % Margin | 58.4% | 54% | 61.5% | 41.2% |
| R&D Expenses | ¥2 | ¥2 | ¥2 | ¥2 |
| G&A Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| SG&A Expenses | ¥4 | ¥5 | ¥4 | ¥4 |
| Sales & Mktg Exp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Operating Expenses | ¥0 | ¥0 | ¥0 | -¥0 |
| Operating Expenses | ¥6 | ¥7 | ¥6 | ¥6 |
| Operating Income | -¥1 | -¥2 | ¥4 | -¥2 |
| % Margin | -5.7% | -19.4% | 23.7% | -19.8% |
| Other Income/Exp. Net | -¥4 | ¥0 | -¥0 | ¥0 |
| Pre-Tax Income | -¥5 | -¥2 | ¥3 | -¥2 |
| Tax Expense | ¥1 | -¥0 | ¥1 | ¥0 |
| Net Income | -¥5 | -¥2 | ¥2 | -¥2 |
| % Margin | -56.7% | -16.3% | 15.4% | -19.9% |
| EPS | -44.84 | -12.55 | 20.09 | -15.7 |
| % Growth | -257.3% | -162.5% | 228% | – |
| EPS Diluted | -44.84 | -12.55 | 20.09 | -15.7 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥0 | ¥0 | ¥0 | ¥0 |
| Interest Expense | ¥0 | ¥0 | ¥0 | ¥0 |
| Depreciation & Amortization | ¥1 | ¥1 | ¥1 | ¥1 |
| EBITDA | -¥3 | -¥0 | ¥4 | -¥1 |
| % Margin | -32.3% | -3.3% | 28.5% | -6% |